Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 7, 2011, Pages 981-989

  Weljie, Aalim M ^a   Jirik, Frank R ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Glycolysis; Hypoxia; Magnetic resonance; Mass spectroscopy; Metabolomics

Indexed keywords

CARBOHYDRATE; GLUTAMIC ACID; GLUTAMINE; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; CANCER CELL; CELL METABOLISM; ENERGY METABOLISM; GAS CHROMATOGRAPHY; GLYCOLYSIS; HUMAN; HYPOXIA; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE PHOSPHORYLATION; PROSTATE CANCER;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; FATTY ACIDS; GLUTAMINE; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOMICS; MICE; MITOCHONDRIA; NEOPLASMS; OXIDATIVE PHOSPHORYLATION;

EID: 79958093404     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.08.009     Document Type: Article

References (95)

1. S. Bandyopadhyay, R. Zhan, Y. Wang, S.K. Pai, S. Hirota, and S. Hosobe Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells Cancer Res 66 2006 5934 5940 (Pubitemid 43927149)
2. J.I. Bárdos, and M. Ashcroft Hypoxia-inducible factor-1 and oncogenic signalling Bioessays 26 2004 262 269 (Pubitemid 38325667)
3. U. Berchner-Pfannschmidt, H. Yamac, B. Trinidad, and J. Fandrey Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2 J Biol Chem 282 2007 1788 1796 (Pubitemid 47076719)
4. R. Bos Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis J Natl Cancer Inst 93 2001 309 314 (Pubitemid 32219818)
5. R. Bos Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma Cancer 97 2003 1573 1581 (Pubitemid 36297788)
6. B. Brune, and J. Zhou Nitric oxide and superoxide: interference with hypoxic signaling Cardiovasc Res 75 2007 275 282 (Pubitemid 46961919)
7. M.T. Canning, L.M. Postovit, S.H. Clarke, and C.H. Graham Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells Exp Cell Res 267 2001 88 94 (Pubitemid 32579144)
8. G. Caso, M.A. McNurlan, N.D. McMillan, O. Eremin, and P.J. Garlick Tumour cell growth in culture: dependence on arginine Clin Sci (Lond) 107 2004 371 379 (Pubitemid 39389304)
9. E.C.Y. Chan Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography-mass spectrometry (GC/MS) J Proteome Res 8 2009 352 361
10. H.H.W. Chen, W.-C. Su, P.-W. Lin, H.-R. Guo, and W.-Y. Lee Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer Breast Cancer Res Treat 103 2007 167 175 (Pubitemid 46789135)
11. D. Corda The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth J Biol Chem 284 2009 24848 24856
12. L.C. Costello, and R.B. Franklin 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis Mol Cell Biochem 280 2005 1 8 (Pubitemid 41829794)
13. J.-P. Dales Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients Int J Cancer 116 2005 734 739 (Pubitemid 41099705)
14. C.V. Dang, J.W. Kim, P. Gao, and J. Yustein The interplay between MYC and HIF in cancer Nat Rev Cancer 8 2008 51 56
15. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab 7 2008 11 20
16. N.C. Denko Hypoxia, HIF1 and glucose metabolism in the solid tumour Nat Rev Cancer 8 2008 705 713
17. M.W. Dewhirst, Y. Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat Rev Cancer 8 2008 425 437 (Pubitemid 351744964)
18. G. Erb Toward improved grading of malignancy in oligodendrogliomas using metabolomics Magn Reson Med 59 2008 959 965 (Pubitemid 351590507)
19. C.J. Eskey, A.P. Koretsky, M.M. Domach, and R.K. Jain Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR Proc Natl Acad Sci USA 90 1993 2646 2650 (Pubitemid 23113473)
20. T.W.M. Fan Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytes Mol Cancer 7 2008 79
21. T.W.M. Fan Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM) Mol Cancer 8 2009 41
22. B.E. Felouati, J.F. Pageaux, J.M. Fayard, M. Lagarde, and C. Laugier Oestradiol-induced changes in the composition of phospholipid classes of quail oviduct: specific replacement of arachidonic acid by docosahexaenoic acid in alkenylacyl-glycerophosphoethanolamine Biochem J 301 1994 361 366 (Pubitemid 24231935)
23. C. Frezza, and E. Gottlieb Mitochondria in cancer: not just innocent bystanders Semin Cancer Biol 19 2009 4 11
24. E. Furuta Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1 Cancer Res 68 2008 1003 1011 (Pubitemid 351278386)
25. R.A. Gatenby Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer Br J Cancer 97 2007 646 653 (Pubitemid 47339892)
26. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 2004 891 899 (Pubitemid 39472955)
27. E. Gazi Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study Anal Bioanal Chem 387 2007 1621 1631
28. K. Glunde Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model Cancer Res 68 2008 172 180 (Pubitemid 351380118)
29. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria as targets for cancer chemotherapy Semin Cancer Biol 19 2009 57 66
30. E. Gottlieb, and I.P. Tomlinson Mitochondrial tumour suppressors: a genetic and biochemical update Nat Rev Cancer 5 2005 857 866 (Pubitemid 41746030)
31. J.L. Griffin, and R.A. Kauppinen Tumour metabolomics in animal models of human cancer J Proteome Res 6 2007 498 505 (Pubitemid 46340153)
32. J.L. Griffin, and J.P. Shockcor Metabolic profiles of cancer cells Nat Rev Cancer 4 2004 551 561 (Pubitemid 38868624)
33. J.R. Griffiths Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumours and tumours deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway Cancer Res 62 2002 688 695 (Pubitemid 34126942)
34. J.R. Griffiths, and M. Stubbs Opportunities for studying cancer by metabolomics: preliminary observations on tumours deficient in hypoxia-inducible factor 1 Adv Enzyme Regul 43 2003 67 76 (Pubitemid 36872823)
35. T. Hamaguchi Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma Int J Oncol 33 2008 725 731
36. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47 (Pubitemid 37328806)
37. C.H. Heldin, K. Rubin, K. Pietras, and A. Ostman High interstitial fluid pressure - an obstacle in cancer therapy Nat Rev Cancer 4 2004 806 813 (Pubitemid 39331152)
38. A. Hirayama Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry Cancer Res 69 2009 4918 4925
39. P.W. Hochachka, J.L. Rupert, L. Goldenberg, M. Gleave, and P. Kozlowski Going malignant: the hypoxia-cancer connection in the prostate Bioessays 24 2002 749 757 (Pubitemid 34850332)
40. S. Izaki, H. Goto, and S. Yokota Increased chemosensitivity and elevated reactive oxygen species are mediated by glutathione reduction in glutamine deprived neuroblastoma cells J Cancer Res Clin Oncol 134 2008 761 768
41. B.F. Jordan, K. Black, I.F. Robey, M. Runquist, G. Powis, and R.J. Gillies Metabolite changes in HT-29 xenograft tumours following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo NMR Biomed 18 2005 430 439 (Pubitemid 41646184)
42. R. Kannagi, J. Yin, K. Miyazaki, and M. Izawa Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants - Hakomori's concepts revisited Biochim Biophys Acta 1780 2008 525 531 (Pubitemid 351381253)
43. Y.I. Kawamura DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer Gastroenterology 135 2008 142-51.e3
44. B. Keith, and M.C. Simon Hypoxia-inducible factors, stem cells, and cancer Cell 129 2007 465 472 (Pubitemid 46660978)
45. J. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab 3 2006 177 185
46. S. Kobayashi, and D.E. Millhorn Hypoxia regulates glutamate metabolism and membrane transport in rat PC12 cells J Neurochem 76 2001 1935 1948 (Pubitemid 32221134)
47. T. Koike Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates Proc Natl Acad Sci USA 101 2004 8132 8137 (Pubitemid 38698066)
48. S. Krishnamoorthy 12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells Exp Cell Res 316 2010 1706 1715
49. F.P. Kuhajda Fatty acid synthesis: a potential selective target for antineoplastic therapy Proc Natl Acad Sci USA 91 1994 6379 6383 (Pubitemid 24200664)
50. F.P. Kuhajda, E.S. Pizer, J.N. Li, N.S. Mani, G.L. Frehywot, and C.A. Townsend Synthesis and antitumour activity of an inhibitor of fatty acid synthase Proc Natl Acad Sci USA 97 2000 3450 3454 (Pubitemid 30183323)
51. S.J. Kwon, and Y.J. Lee Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells Clin Cancer Res 11 2005 4694 4700 (Pubitemid 41557187)
52. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 2001 3995 4004 (Pubitemid 32476461)
53. S.H. Lee, M.Y. Lee, and H.J. Han Short-period hypoxia increases mouse embryonic stem cell proliferation through cooperation of arachidonic acid and PI3K/Akt signalling pathways Cell Prolif 41 2008 230 247 (Pubitemid 351367492)
54. H. Lu, R.A. Forbes, and A. Verma Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis J Biol Chem 277 2002 23111 23115 (Pubitemid 34952134)
55. J.C. Maher, A. Krishan, and T.J. Lampidis Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumour cells treated under hypoxic vs aerobic conditions Cancer Chemother Pharmacol 53 2004 116 122 (Pubitemid 38186989)
56. A. Marín-Hernández, J.C. Gallardo-Pérez, S.J. Ralph, S. Rodríguez-Enríquez, and Moreno-Sánchez R HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms Mini Rev Med Chem 9 2009 1084 1101
57. G. Maschek 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo Cancer Res 64 2004 31 34 (Pubitemid 38114078)
58. S. Mathieu Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumour growth Int J Cancer 121 2007 1680 1689 (Pubitemid 47417283)
59. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase-2 bound to mitochondria: Cancer's stygian link to the "Warburg effect" and a pivotal target for effective therapy Semin Cancer Biol 19 2009 17 24
60. R. Mazzanti Differential expression proteomics of human colon cancer Am J Physiol Gastrointest Liver Physiol 290 2006 G1329-1338
61. G. Medes, A. Thomas, and S. Weinhouse Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro Cancer Res 13 1953 27 29
62. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 2007 763 777 (Pubitemid 47469806)
63. K. Mikuriya Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry Int J Oncol 30 2007 849 855
64. D. Morvan, A. Demidem, J. Papon, M. De Latour, and J.C. Madelmont Melanoma tumours acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumour samples Cancer Res 62 2002 1890 1897 (Pubitemid 34408518)
65. U.M. Muñoz-Nájar, K.M. Neurath, F. Vumbaca, and Claffey KP Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation Oncogene 25 2006 2379 2392
66. S. Nanni Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer J Clin Invest 119 2009 1093 1108
67. O.E. Owen, S.C. Kalhan, and R.W. Hanson The key role of anaplerosis and cataplerosis for citric acid cycle function J Biol Chem 277 2002 30409 30412 (Pubitemid 34970728)
68. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and Denko NC HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab 3 2006 187 197
69. A.G. Payne Exploiting hypoxia in solid tumours to achieve oncolysis Med Hypotheses 68 2007 828 831 (Pubitemid 46136784)
70. A.E. Pegg Regulation of ornithine decarboxylase J Biol Chem 281 2006 14529 14532 (Pubitemid 43855154)
71. H. Pelicano, D.S. Martin, R. Xu, -H, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646 (Pubitemid 44187614)
72. A. Perrin Pyruvate reverses metabolic effects produced by hypoxia in glioma and hepatoma cell cultures Biochimie 84 2002 1003 1011 (Pubitemid 36040533)
73. P.J. Pollard, and Ratcliffe PJ Cancer: puzzling patterns of predisposition Science 324 2009 192 194
74. J. Pouysségur, F. Dayan, and Mazure NM Hypoxia signalling in cancer and approaches to enforce tumour regression Nature 441 2006 437 443 (Pubitemid 44050138)
75. L.D. Roberts, G. McCombie, C.M. Titman, and J.L. Griffin A matter of fat: an introduction to lipidomic profiling methods J Chromatogr B: Analyt Technol Biomed Life Sci 871 2008 174 181
76. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"? - Akt-energy metabolism interactions and oncogenesis Semin Cancer Biol 19 2009 25 31
77. K.M.A. Rouschop, and B.G. Wouters Regulation of autophagy through multiple independent hypoxic signaling pathways Curr Mol Med 9 2009 417 424
78. G.L. Semenza Regulation of cancer cell metabolism by hypoxia-inducible factor 1 Semin Cancer Biol 19 2009 12 16
79. N.J. Serkova, and K. Glunde Metabolomics of cancer Methods Mol Biol 520 2009 273 295
80. D.R. Shalinsky, D.B. McNamara, and K.C. Agrawal Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole Cancer Res 49 1989 3853 3856 (Pubitemid 19197410)
81. H. Soh, M. Wasa, and M. Fukuzawa Hypoxia upregulates amino acid transport in a human neuroblastoma cell line J Pediatr Surg 42 2007 608 612 (Pubitemid 46589519)
82. S. Suzuki, A. Oguro, M. Osada-Oka, Y. Funae, and S. Imaoka Epoxyeicosatrienoic acids and/or their metabolites promote hypoxic response of cells J Pharmacol Sci 108 2008 79 88
83. C.B. Thompson Metabolic enzymes as oncogenes or tumour suppressors N Engl J Med 360 2009 813 815
84. V.P. Tissot, and C. Martha Enhanced leukocyte HIF-1alpha and HIF-1 DNA binding in humans after rapid ascent to 4300 m Free Radic Biol Med 46 2009 1551 1557
85. D. Wang, and R.N. DuBois Measurement of eicosanoids in cancer tissues Meth Enzymol 433 2007 27 50
86. D. Wang, and R.N. DuBois Eicosanoids and cancer Nat Rev Cancer 10 2010 181 193
87. A. Weigert, and B. Brune Nitric oxide, apoptosis and macrophage polarization during tumour progression Nitric Oxide 19 2008 95 102
88. A. Weljie, R. Dowlatabadi, B. Miller, H. Vogel, and F. Jirik An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy J Proteome Res 6 2007 3456 3464 (Pubitemid 47522736)
89. B.G. Wouters, and M. Koritzinsky Hypoxia signalling through mTOR and the unfolded protein response in cancer Nat Rev Cancer 8 2008 851 864
90. R.-H. Xu Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 65 2005 613 621
91. S.J. Yeung, J. Pan, and M.-H. Lee Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer Cell Mol Life Sci 65 2008 3981 3999
92. J. Yin, K. Miyazaki, R.L. Shaner, A.H. Merrill, and R. Kannagi Altered sphingolipid metabolism induced by tumour hypoxia - new vistas in glycolipid tumour markers FEBS Lett 584 2010 1872 1878
93. S. Zhao Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 324 2009 261 265
94. B. Zhivotovsky, and S. Orrenius The Warburg effect returns to the cancer stage Semin Cancer Biol 19 2009 1 3
95. J. Zhou, T. Schmid, S. Schnitzer, and B. Brüne Tumour hypoxia and cancer progression Cancer Lett 237 2006 10 21